John Hester
Stock Analyst at Bell Potter
(4.16)
# 1,551
Out of 4,501 analysts
204
Total ratings
47.9%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CYC Cyclopharm Limited | Maintained: Buy | $1.00 | $0.525 | +90.48% | 14 | Jul 6, 2026 | |
| ASX: EIQ Echo IQ Limited | Downgraded: Hold | $1.65 → $1.75 | $1.66 | +5.42% | 2 | Jul 3, 2026 | |
| ASX: MSB Mesoblast Limited | Maintained: Buy | $4.45 | $2.24 | +98.66% | 19 | Jul 2, 2026 | |
| ASX: PAR Paradigm Biopharmaceuticals Limited | Maintained: Buy | $0.65 → $0.45 | $0.17 | +164.71% | 10 | Jun 18, 2026 | |
| ASX: PGC Paragon Care Limited | Downgraded: Hold | $0.30 → $0.17 | $0.14 | +21.43% | 17 | Jun 2, 2026 | |
| ASX: 4DX 4DMedical Limited | Maintained: Buy | $4.50 → $6.00 | $3.96 | +51.52% | 13 | Jun 2, 2026 | |
| ASX: IMU Imugene Limited | Maintained: Buy | $0.25 | $0.105 | +138.10% | 7 | May 28, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $1.12 → $1.09 | $0.59 | +84.75% | 6 | May 26, 2026 | |
| ASX: DOC Doctor Care Anywhere Group PLC | Upgraded: Buy | $0.20 → $0.24 | $0.122 | +96.72% | 4 | May 21, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $19.00 | $16.27 | +16.78% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $240.00 → $226.00 | $197.07 | +14.68% | 15 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.40 → $6.50 | $2.41 | +169.71% | 19 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.00 → $13.00 | $13.34 | -2.55% | 4 | Mar 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.00 | $2.82 | +6.38% | 4 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $4.10 → $3.60 | $3.24 | +11.11% | 16 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.00 → $1.80 | $1.02 | +77.34% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.05 → $0.06 | $0.019 | +215.79% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.017 | +782.35% | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.003 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.87 → $3.85 | $3.91 | n/a | 3 | Nov 25, 2022 |
Cyclopharm Limited
Jul 6, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.525
Upside: +90.48%
Echo IQ Limited
Jul 3, 2026
Downgraded: Hold
Price Target: $1.65 → $1.75
Current: $1.66
Upside: +5.42%
Mesoblast Limited
Jul 2, 2026
Maintained: Buy
Price Target: $4.45
Current: $2.24
Upside: +98.66%
Paradigm Biopharmaceuticals Limited
Jun 18, 2026
Maintained: Buy
Price Target: $0.65 → $0.45
Current: $0.17
Upside: +164.71%
Paragon Care Limited
Jun 2, 2026
Downgraded: Hold
Price Target: $0.30 → $0.17
Current: $0.14
Upside: +21.43%
4DMedical Limited
Jun 2, 2026
Maintained: Buy
Price Target: $4.50 → $6.00
Current: $3.96
Upside: +51.52%
Imugene Limited
May 28, 2026
Maintained: Buy
Price Target: $0.25
Current: $0.105
Upside: +138.10%
Aroa Biosurgery Limited
May 26, 2026
Maintained: Buy
Price Target: $1.12 → $1.09
Current: $0.59
Upside: +84.75%
Doctor Care Anywhere Group PLC
May 21, 2026
Upgraded: Buy
Price Target: $0.20 → $0.24
Current: $0.122
Upside: +96.72%
Telix Pharmaceuticals Limited
May 8, 2026
Maintained: Buy
Price Target: $19.00
Current: $16.27
Upside: +16.78%
Apr 14, 2026
Maintained: Buy
Price Target: $240.00 → $226.00
Current: $197.07
Upside: +14.68%
Apr 1, 2026
Maintained: Buy
Price Target: $6.40 → $6.50
Current: $2.41
Upside: +169.71%
Mar 8, 2026
Maintained: Buy
Price Target: $10.00 → $13.00
Current: $13.34
Upside: -2.55%
Feb 27, 2026
Maintained: Hold
Price Target: $3.00
Current: $2.82
Upside: +6.38%
Feb 24, 2026
Upgraded: Hold
Price Target: $4.10 → $3.60
Current: $3.24
Upside: +11.11%
Feb 23, 2026
Maintained: Buy
Price Target: $2.00 → $1.80
Current: $1.02
Upside: +77.34%
Dec 17, 2025
Maintained: Buy
Price Target: $0.05 → $0.06
Current: $0.019
Upside: +215.79%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.017
Upside: +782.35%
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.003
Upside: n/a
Nov 25, 2022
Maintained: Hold
Price Target: $4.87 → $3.85
Current: $3.91
Upside: n/a